From: Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
 | Diet | Diet-plus-statin | ||||
---|---|---|---|---|---|---|
 | Baseline | 6 months | 12 months | Baseline | 6 months | 12 months |
Renal function: | Â | Â | Â | Â | Â | Â |
 Estimated GFR (mL/min/1.73 m2) | 50.1 ± 4.9 | 45.1 ± 4.3* | 45.9 ± 4.3* | 48.6 ± 4.7 | 45.6 ± 4.5* | 45.1 ± 5.3* |
 UACR (mg/g-Cr) | 1025 ± 465 | 671 ± 220 | 687 ± 249 | 801 ± 254 | 714 ± 233 | 557 ± 186 |
Oxidative stress: | Â | Â | Â | Â | Â | Â |
 Pentosidine (ng/mL) | 40 ± 4 | 28 ± 3* | 24 ± 3* | 46 ± 7 | 38 ± 7 | 34 ± 6* |